K. Colvett

Bilateral breast carcinoma after radiation therapy for Hodgkin's disease.

K. Colvett, 1995, Southern medical journal.

High PCNA index in meningiomas resistant to radiation therapy.

F. S. Pardo, M. Su, D. Hsu, 1997, International journal of radiation oncology, biology, physics.

Opportunities with combined modality therapy for selective organ preservation in muscle‐invasive bladder cancer

A. Zietman, W. Shipley, A. Althausen, 1996, Journal of surgical oncology.

Atypical Presentation of Metastatic Basal Cell Carcinoma

Ryan A Stanton, K. Colvett, F. Wilson, 2004, Southern medical journal.

Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC)

D. Sher, J. Bianco, S. Sonis, 2020 .

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

J. Buatti, J. Holmlund, J. Wheeler, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonsurgical treatment of laryngeal cancer.

K. Colvett, 2004, The New England journal of medicine.

PREVLAR: Phase 2a randomized trial to assess the safety and efficacy of RRx-001 in the attenuation of oral mucositis in patients receiving head and neck chemoradiotherapy.

K. Niermann, D. Sher, M. Biagioli, 2023, International journal of radiation oncology, biology, physics.